Drug-Related Problem Classification Systems

Annals of Pharmacotherapy

Volumn 38, Issue 5, 2004, Pages 859-867

  Van Mil, J W Foppe ^a,b,g   Westerlund, L O Tommy ^c,d   Hersberger, Kurt E ^e   Schaefer, Marion A ^f  

^a Van Mil Consultancy   (Netherlands)

^b Qual Inst for Pharmaceutical Care   (Netherlands)

^c Apoteket AB   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UNIVERSITY OF BASEL   (Switzerland)

^f HUMBOLDT UNIVERSITY   (Germany)

^g NONE   (Netherlands)

Author keywords

Classifications; Drug related problems; Drug therapy problems; Medication errors; Medicine related problems; Pharmaceutical care; Pharmacotherapy

Indexed keywords

CYTOSTATIC AGENT; DRUG;

CLINICAL PRACTICE; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG INDUCED DISEASE; DRUG USE; EUROPE; HUMAN; MEDICAL LITERATURE; MEDICATION ERROR; PHARMACEUTICAL CARE; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STANDARDIZATION; SYSTEM ANALYSIS; SYSTEMATIC REVIEW; TECHNIQUE; TREATMENT OUTCOME; VALIDATION PROCESS;

MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS;

EID: 1942534700     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D182     Document Type: Review

References (35)

1. Currie JD, Doucette WR, Kuhle J, Sobotka J, Miller WA, McDonough RP, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc 2003;43:41-9.
2. ATC Codes. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, Norway. 2003. www.whocc.nmd.no (accessed 2004 Mar 22).
3. Espejo J, Fernández-Llimós F, Machucha M, Faus MJ. [Drug-related problems: definition and proposal for its inclusion in the International Classification of Primary Care (ICPC) from WONCA] Spanish. Pharm Care Esp 2002;4:122-7.
4. Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120-7.
5. Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000;22:415-23.
6. ASHP guidelines on a standardized method for pharmaceutical care. In: Deffenbaugh J, ed. Best practices for health-system pharmacy. Bethesda, MD: American Society of Health-System Pharmacists, 1996:109-11.
7. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill, 1998:78-9.
8. Grupo de Investigacíon en Aténcion Farmacéutica. [The second Granada consensus on drug-related problems] Spanish. Ars Pharmaceutica 2002; 43:175-84.
9. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045-51.
10. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
11. Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, et al. A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 2002;10:91-100.
12. Mackie CA. Randomised controlled trial of medication review. In: Repeat prescribing in general practice: the development and evaluation of methodologies to improve the quality and cost-effectiveness of repeat prescribing (thesis). University of Strathclyde, Glasgow, UK, 2002.
13. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). About medication errors. www.nccmerp.org/aboutmederrors.htm (accessed 2003 Jan 21).
14. van Mil JWF, Tromp ThFJ. Coding frequently asked questions during the pharmaceutical care process with the Pas System. J Appl Ther 1997;1:351-5.
15. Pharmaceutical Care Network Europe. DRP-classification V4.0. www. pcne.org/dokumenter/PCNE%20scheme%20V400.htm (accessed 2003 May 26).
16. [Proposals for adaptation of the SEP-codes] Dutch. Houten, the Netherlands: SHB PlusPunten, Jan 14 2003:15.
17. Westerlund T. Drug-related problems: identification, characteristics and pharmacy interventions (dissertation). Department of Social Medicine, Göteborg University, Göteborg, Sweden, 2002:25-6.
18. Pharmacist Practice Activity Classification 1.0. www.aphanet.org/lead/practiceclass.html (accessed 2003 Jun 9).
19. ASHP statement on pharmaceutical care. Am J Hosp Pharm 1993;50: 1720-3.
20. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990;24:1093-7.
21. Consensus Panel ad hoc. Consensus of Granada on drug-related problems. Pharm Care Esp 1999;1:107-12.
22. Kassam R, Martin LG, Farris KB. Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003;37:40-6. DOI 10.1345/aph1C077
23. Schmader KE, Hanlon JT, Landsman PB, Samsa GP, Lewis IK, Weinberger M. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997;31:529-33.
24. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002;22:915-23.
25. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11.
26. Ijben G, van Mil JWF, Tromp TFJ, de Jong-van den Berg LTW. Quantification of communication processes, is it possible? Pharm World Sci 1999;21:195-9.
27. van Mil JWF, Winterstein A. Documenting system for drug-related problems: preliminary validation report V, 1.2. 2001. www.pcne.org/dokumenter/DRP%20val%20V12_Bev.pdf (accessed 2003 May 26).
28. Santos C, Madeira A. Using the PCNE classification in Portugal. Presentation at DRP symposium, Hillerod 16 Feb 2003. www.pcne.org/dokumenter/presentation%20Santos.pfd (accessed 2003 Mar 31).
29. Schaefer M. [How indispensable are pharmacists? Results of a study on documenting drug-related problems in the pharmacy] German. Deutsche Apotheker Zeitung 1995;33:3019-27.
30. Aagaard Larsen L, West Sorensen E, Toft T, Møller M. Pharmacy University Project 1999-2001. Presentation at DRP symposium 16 Feb 2003. www.pcne.org/dokumenter/presentation%20Larsen.pfd (accessed 2003 Mar 31).
31. Westerlund T, Almarsdóttir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract 1999;7:40-50.
32. Westerlund T. A national pharmacy chain-pros and cons of the Swedish system. J Manage Pharmaceut Care 2001;1:83-8.
33. Westerlund LOT, Handl WHA, Marklund BRG, Allebeck P. Pharmacy practitioners' views on computerized documentation of drug-related problems. Ann Pharmacother 2003;37:354-60. DOI 10.1345/aph.1C182.
34. Handl W, Thunberg M, Westerlund T. [Educational material] Swedish. Stockholm: Apoteket AB, 2001.
35. Andersson AC, Brodin H, Nilsson JL. Pharmacist interventions in relation to patient drug-related problems. J Soc Adm Pharm 2003;20:82-90.